Company: MKDWW
Filing Date: 2025-04-03
Form Type: 20-F
Source: 0001641172-25-002607
Chunk: 32

Company: MKDWELL Tech Inc.
Filing Date: 2025-04-03
Form: 20-F
Item: Item 3
Chunk 32
---
 the listing
of its securities from The Nasdaq Global Market to The Nasdaq Capital Market and meet the continued listing requirement for market value
of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, except for the Minimum Bid Price Requirement.
Additionally, the Company would need to provide written notice of its intention to cure the deficiency during the second compliance period.
If Nasdaq determines that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible for the additional
compliance period, Nasdaq will provide notice that the Ordinary Shares will be subject to delisting. The Company would have the right
to appeal a determination to delist its Ordinary Shares to a hearings panel. The Company intends to actively monitor the closing bid
price of the Ordinary Shares and will evaluate available options to regain compliance with the Minimum Bid Price Requirement. However,
there can be no assurance that the Company will regain compliance during the initial 180-day compliance period, secure a second compliance
period or maintain compliance with the other Nasdaq Listing Rules.

On
September 19, 2024, the Company received a notification letter from Nasdaq, indicating that the Company was no longer in compliance with
the minimum Market Value of Listed Securities (“ MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global
Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “ MVLS Requirement”) since the Company failed to meet the MVLS
Requirement for a period of 30 consecutive business days from August 5, 2024 to September 18, 2024. Consequently, the Company applied
for a transfer of its ordinary shares from the Nasdaq Global Market to the Nasdaq Capital Market. On March 20, 2025, Nasdaq notified
the Company that it had approved the Company’s application to list its ordinary shares on the Nasdaq Capital Market. The listing
of the Company’s Ordinary Shares were transferred to the Nasdaq Capital Market at the opening of business on March 25, 2025.

  18  

To
remedy any deficit in funds or shareholder equity in order to satisfy Nasdaq’s continuing listing standards or other minimum bid
price requirements, if any, the Company may have to raise additional funding through dilutive equity investments or other external sources,
but there is no certainty such external funding will be available or on acceptable terms, or the Company may have to conduct reverse
stock splits to consolidate